Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
CXSL2101301 | 人凝血因子Ⅷ/血管性血友病因子复合物 | Lyophilized | Biological Products(3.2) | New Drug Application | 2021-09-02 | Shandong Taibang Biological Products Co Ltd | view | ||||
CXSL2101300 | 人凝血因子Ⅷ/血管性血友病因子复合物 | Lyophilized | Biological Products(3.2) | New Drug Application | 2021-09-02 | Shandong Taibang Biological Products Co Ltd | view |